We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · March 03, 2016

Anamorelin in Patients With Non–Small Cell Lung Cancer and Cachexia

The Lancet Oncology


Additional Info

The Lancet Oncology
Anamorelin in Patients With Non-Small-Cell Lung Cancer and Cachexia (ROMANA 1 and ROMANA 2): Results From Two Randomised, Double-Blind, Phase 3 Trials
Lancet Oncol 2016 Feb 19;[EPub Ahead of Print], JS Temel, AP Abernethy, DC Currow, J Friend, EM Duus, Y Yan, KC Fearon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.